GALECTIN THERAPEUTICS INC 4
4 · GALECTIN THERAPEUTICS INC · Filed Sep 6, 2013
Insider Transaction Report
Form 4
MAULDIN JOHN F
Director
Transactions
- Purchase
Common Stock
2013-09-04$7.38/sh+676$4,988→ 15,868 total
Holdings
- 4,947(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2013.
- [F2]Reflects weighted average price. Range of prices were between $7.36 and $7.39. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.